Anastasia Zimina - Dept Oncol, Omsk Clin Oncol Dispensary

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 7 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract GS01-03: Adding Atezolizumab to Adjuvant Chemotherapy for Stage II and III Triple-Negative Breast Cancer is Unlikely to Improve Efficacy: Interim Analysis of the ALEXANDRA/IMpassion030 Phase 3 Trial

Michail Ignatiadis,Andrew Bailey,Heather McArthur,Sarra El-Abed,Evandro de Azambuja,Otto Metzger, Steve Chui, Max Dieterich, Thomas Perretti,Guenther Steger,Jacek Jassem,Soo Chin Lee,Michaela Higgins, José Zarbá,Marcus Schmidt,Henry Gomez,Angel Guerrero-Zotano,Luca Moscetti,Joanne Win Yang Chiu,Carter DuFrane,Vanessa Honvault, Rosa Altarcheh,Luciana Molinero, Andrew Ellingson,Elisabetta Munzone,Noa Efrat Ben-Baruch,Emilio Bajetta,Shinji Ohno,Seock-Ah Im,Gustavo Werutsky,Einav Gal-Yam,Xavier Gonzalez-Farré,Ling-Ming Tseng,William Jacot,Oleg Gluz,Zhimin Shao,Yaroslav Shparyk, Ivan Sinielnikov,Zimina Anastasia, Aleksandr Vasiliev, Esther Shearer-Kang,Eric Winer,Diogo Martins-Branco,Shona Fielding,David Cameron,Giuseppe Viale,Shigehira Saji,Richard Gelber,Martine Piccart

Cancer Researchno. 9_Supplement (2024): GS01-03

Cited0Views0Bibtex

Abstract 6390: Exploratory biomarker analysis of phase 3 ASTRUM-005 study: Serplulimab versus placebo plus chemotherapy for extensive-stage small cell lung cancer

Ying Cheng,Liang Han,Lin Wu,Jun Chen,Hongmei Sun,Guilan Wen,Yinghua Ji,Anastasia Zimina,Jianhua Shi,Zhijie Pan,Jinsheng Shi,Xicheng Wang, Fang Yang, Xinyi Yang, Mengkai Chen, Shiqi Zhong,Qingyu Wang, Jing Li,Jiancheng Cheng,Chen Ling, Yongqiang Shan,Jun Zhu

Cancer Researchno. 6_Supplement (2024): 6390-6390

Cited0Views0Bibtex

139MO Tislelizumab (TIS) Plus Chemotherapy (chemo) Vs Placebo (PBO) Plus Chemo As First-Line (1L) Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (GC/GEJC): Final Analysis Results of the RATIONALE-305 Study

R-H. Xu, Do‐Youn Oh,Ken Kato,H-T. Arkenau,Josep Tabernero,Marcia Cruz–Correa,Anastasia Zimina,Yuxian Bai,Jingwen Shi, Lee Kw,Hidekazu Hirano,David R. Spigel,Lucjan Wyrwicz,Roberto Pazo-Cid, L. Li, Yangsheng Xu,M. Brent McHenry,Silu Yang,Markus Moehler

Annals of oncology (2023): S1526-S1527

Cited0Views0Bibtex

Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis

Journal of thoracic oncologyno. 12 (2023): 1756-1766

Cited1Views0WOSBibtex

Lazertinib Versus Gefitinib As First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results from LASER301

Journal of clinical oncologyno. 26 (2023): 4208-4217

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn